Evidence for the carcinogenicity of TCE in humans comes from several cohort studies where specific TCE exposures were well characterized for individual study subjects.
A meta-analysis of these cohort studies found that occupational exposure to TCE was associated with excess incidences of liver cancer, kidney cancer, non-Hodgkin's lymphoma, prostate cancer, and multiple myeloma, with the strongest evidence for the first three cancers (Wartenberg, Reyner et al. 2000; NTP 2004). It is important to note that the conclusions drawn in these studies were based on a relatively small number of exposed workers and were confounded by exposure to other solvents and other risk factors. Other studies did not reveal any excess cancer mortality from low exposures to TCE (Axelson, Andersson et al. 1978; Tola, Vilhunen et al. 1980; Shindell and Ulrich 1985; Spirtas, Stewart et al. 1991; Axelson, Selden et al. 1994).
A study (Massachusetts Department of Public Health 1996) performed in Woburn, Massachusetts by the Massachusetts Department of Health (1996) found an elevated risk of childhood leukemia in a group exposed to TCE in utero.
The New Jersey study (Bove, Fulcomer et al. 1995) found associations with childhood leukemia among females and with non-Hodgkin's lymphoma.
A review on mutagenicity of TCE and its metabolites indicated that TCE and its metabolites are not potent genotoxic agents and require high doses to induce a response (Moore and Harrington-Brock 2000). The full tumor development is likely to require promotional stimuli under high (suggested: >500 ppm peak exposures) and long-term (several years) exposure to TCE (Bolt, Lammert et al. 2004).
A cohort study of 169 male workers having been exposed to unusually high levels of TCE in Germany between 1956 and 1975 supported a nephrocarcinogenic effect of TCE in humans. A further case-control study confirmed the results of the previous cohort study, supporting the concept of involvement of prolonged and high-dose TCE exposures in the development of renal cell cancer (Bruning and Bolt 2000). The finding of a TCE-specific mutation of the von Hippel-Landau (VHL) tumor suppressor gene, a gene associated with kidney tumors, provides strong evidence that TCE causes kidney cancer (Brauch, Weirich et al. 1999).
A study of three Michigan communities exposed to chlorinated solvents, including TCE in drinking water, showed no significant increase in cancers, including leukemia, among the exposed population. However, the cohort size in the study was only 223 (Agency for Toxic Substances and Disease Registry 1997). A study of 4,280 people exposed to TCE and other contaminants in drinking water in three states reported an increase in respiratory tract cancer in males. The study authors concluded that, based on the incidence of smoking in the population, “it would be inappropriate to relate this excess solely to TCE exposure” (Agency for Toxic Substances and Disease Registry 1997).
The findings in humans are supported by evidence of carcinogenicity in experimental animals, in which tumors occurred at several of the same sites as in humans. Inhalation or oral exposure to high doses of TCE produces liver and lung tumors in mice (Maltoni, Lefemine et al. 1988), and renal adenocarcinomas, testicular tumors, and possibly leukemia in rats (Maltoni, Lefemine et al. 1988).
However, it is important to understand interspecies differences in TCE metabolism and pharmacokinetics in order to reduce uncertainties inherent in species-to-species extrapolations (Bruckner, Davis et al. 1989).
Many studies reviewed by the International Agency for Research on Cancer (IARC) examined the relationship between TCE exposure and kidney and liver cancer mortality or incidence. Most of studies were of occupational exposures (Bull 2000; Lash, Parker et al. 2000).
In conclusion, TCE is reasonably anticipated to be a human carcinogen based on limited evidence of carcinogenicity from studies in humans, sufficient evidence of carcinogenicity from studies in experimental animals, which indicates there is an increased incidence of malignant and/or a combination of malignant and benign tumors at multiple tissue sites in multiple species of experimental animals, and information suggesting TCE acts through mechanisms that indicate it would likely cause cancer in humans (NTP 2004). |